Comparative Plasma Levels of Mephenesin, Mephenesin Carbamate and Methocarbamol.

Huf, Ernst G.; Coles, Frances K.; Eubank, Leah L.

doi:10.3181/00379727-102-25218

Search citation statements

Order By: Relevance

Paper Sections

Select...

Chlorphenesin Carbamate [3-(p-chlorophenoxy)-12-propanediol2

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1962

1992

Publication Types

Select...

Book3

Article2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 10 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, it may be concluded that the observed differences reflect extensive distribution of chlorphenesin carbamate relative to methocarhamol A similar pattern is seen in the comparative plasma levels of mephenesin carbamate and methocarbamol reported by Huf'et a/. (16). The mean biological half-life of 3.14 hr.…”

Section: Chlorphenesin Carbamate [3-(p-chlorophenoxy)-12-propanediolsupporting

confidence: 60%

“…Accordingly, the present study was conducted to characterize the pharmacokinetics of chlorphenesin carbamate in man. Earlier investigations in man with mephenesin carbamate (1 5) and methocarbamol [3-(0-methoxyphenoxy)-l,2-propanediol-l-carbamate] (16) indicated higher and more prolonged plasma levels for the latter. However, no determination of pharrnacokinetic parameters was possible from the data presented.…”

Section: Chlorphenesin Carbamate [3-(p-chlorophenoxy)-12-propanediolmentioning

confidence: 99%

See 1 more Smart Citation